Updated Jul 16, 2026
Thompson Travis Alvin has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $174K.

Travis Alvin Thompson is the Chief Accounting Officer at Bicycle Therapeutics PLC, a clinical-stage biopharmaceutical company focused on developing innovative medicines. He has been involved in multiple SEC filings related to the company's financial activities.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-07 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 104 | $4.31 | $448 |
| 2026-07-07 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 819 | $4.27 | $3K |
| 2026-04-06 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 102 | $5.05 | $515 |
| 2026-04-06 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 799 | $4.91 | $4K |
| 2025-10-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 103 | $8.41 | $866 |
| 2025-10-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 221 | $8.40 | $2K |
| 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 100 | $7.44 | $744 |
| 2025-07-02 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 206 | $7.09 | $1K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 231 | $24.82 | $6K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 209 | $24.77 | $5K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 3.2K | $25.21 | $82K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 1.1K | $25.05 | $28K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | M — Option exercise [10b5-1] | 1.1K | $9.82 | $11K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 154 | $25.01 | $4K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | M — Option exercise [10b5-1] | 154 | $8.21 | $1K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale [10b5-1] | 1.3K | $25.05 | $33K |
| 2024-11-13 | BCYC | BICYCLE THERAPEUTICS PLC | M — Option exercise [10b5-1] | 1.3K | $1.87 | $2K |
| 2024-10-04 | BCYC | BICYCLE THERAPEUTICS PLC | S — Open-market sale | 153 | $22.26 | $3K |
Travis Alvin Thompson is the Chief Accounting Officer at Bicycle Therapeutics PLC, a clinical-stage biopharmaceutical company focused on developing innovative medicines. He has been involved in multiple SEC filings related to the company's financial activities.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 15 open-market sales ($174K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Thompson Travis Alvin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.